Hematologic toxicities, sarcopenia, and body composition change in breast cancer patients undergoing neoadjuvant chemotherapy
MK Jang, S Park, C Park, A Doorenbos, J Go… - Supportive Care in …, 2023 - Springer
Purpose Evaluation of body composition and sarcopenia status could provide evidence for
more sensitive prediction of chemotherapy toxicities and support mitigation of the negative …
more sensitive prediction of chemotherapy toxicities and support mitigation of the negative …